Description: Prana Biotechnology is developing first-in-class therapies to treat neurodegenerative disease.
Home Page: alteritytherapeutics.com
350 Collins Street
Melbourne,
VIC
3000
Australia
Phone:
61 3 9349 4906
Officers
| Name | Title |
|---|---|
| Mr. Geoffrey Paul Kempler B.Sc. | Co-Founder & Non-Executive Chairman |
| Dr. David A. Stamler M.D. | Chief Executive Officer |
| Ms. Abby Macnish Niven B.Com., B.Sc., C.F.A. | CFO & Company Secretary |
| Dr. Rudolph Emile Tanzi Ph.D. | Chief Scientific Advisor and Member of Research & Development Advisory Board |
| Dr. Steven D. Targum M.D. | Chief Medical Advisor |
| Dr. Robert Cherny | Head of Research |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.0386 |
| Price-to-Sales TTM: | 4.6984 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 10 |